Home » Anna Du

Anna Du

Senior Analyst

Anna Du is a Senior Analyst at CBPartners.

Connect with Anna Du

anna.du@cbpartners.com

LinkedIn

Published Articles

ISPOR Asia-Pacific 2020: China’s 2019 NRDL Update – Implications on Global & Local Manufacturer Strategy

A research poster to evaluate 2019 NRDL negotiation outcomes as indicators of potential strategic approaches for multinational and domestic manufacturers to achieve NRDL listing.

Alzheimer’s and Aducanumab: The Beta Amyloid Theory’s Last Hope

Clinical Trial Disruptions: Can Small-Cap Biopharma Companies Weather the Impact of COVID-19?

Cumulative costs from patient enrollment scenarios due to COVID-19 will likely generate a significant financial drain on biopharma R&D expenditures. CBPartners' blog post investigates this impact and explores mitigation strategies.